Weill Medical College of Cornell University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Weill Medical College of Cornell University sits in the top decile of US sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count).
Weill Medical College of Cornell University: 701 sponsored US clinical trials, 127 recruiting.
Weill Medical College of Cornell University sponsors 701 registered US clinical trials on ClinicalTrials.gov, 127 of them currently recruiting, and 387 completed. 89 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 20 trials.
Top-decile sponsor footprint
Weill Medical College of Cornell University ranks in the top decile of sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
387 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
701 total, page 8 of 15
Pain Screening in Refugee Survivors of Torture
NCT03018782
The Efficacy of a New Mathematical Formula to Predict Continuous Positive Air Pressure With an Oronasal Mask Interface.
NCT02816255
Impact of Duloxetine on Male Fertility
NCT03038867
Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung Cancer
NCT02904954
A Phase II Randomized Trial of Immunotherapy Plus Radiotherapy in Metastatic Genitourinary Cancers
NCT03115801
Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC)
NCT02516384
Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer
NCT02911922
Can Cognitive Training Decrease Reactive Aggression?
NCT03623477
Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MS
NCT02446886
Biology of the Oral Epithelium of E-Cigarette Smokers
NCT03028558
Mechanisms of Ischemic Stroke in Cancer Patients
NCT02604667
Improving Medication Adherence in the Alabama Black Belt
NCT02274844
Evaluation of the Effect of Dried Cranberry Powder in Women With Dry OAB
NCT03017170
Strides for Life I: Increasing Physical Activity in Stage 1 Lung Cancer Patients
NCT02755883
Peer Mentored Approaches For Men And Women With Coronary Artery Disease ("4Steps")
NCT03020316
A Phase II Study of SGI-110 in Philadelphia-Negative Myeloproliferative Neoplasms
NCT03075826
A ProspectiveTrial Comparing THUNDERBEAT to the Ligasure Energy Device During Laparoscopic Colon Surgery
NCT02628093
Neoadjuvant J591 Treatment for Prostate Cancer
NCT02693860
Prospective, Double Blind, Placebo Control, Bariatric IV Ace
NCT02452320
BiRd vs. Rd as Initial Therapy in Multiple Myeloma
NCT02516696
An 18-Month Psychotherapy of Borderline Personality Disorder
NCT03329677
Safety of Caprylic Triglycerides in ALS: A Pilot Study
NCT02716662
Essential Voice Tremor: A Study of Botulinum Toxin Treatment and Injection Augmentation
NCT02711995
KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma
NCT02471911
The Effect of White Noise In High Noise Environment
NCT02647138
Polymorphisms at Distinct Genetic Loci Affect Response to Anti-CD20 Monoclonal Antibody Therapies
NCT02694913
Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program)
NCT02574273
Trial of RiaSTAP Versus Cryoprecipitate to Lower Operative Transfusions
NCT02540434
IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia
NCT02508324
LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer
NCT02538471
Immune Modulators and IVF
NCT02626702
Delayed Cord Clamping in Preterm Neonates
NCT02478684
J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell Counts
NCT02552394
Commercial Single Step (Vitrolife -G-TL™) Media Compared With Cornell Media
NCT02527642
Pacritinib Combined With Decitabine or Cytarabine in Older Patients With AML
NCT02532010
Mobile Phone Technology for Chronic Pain Patients- A Feasibility Study
NCT02447107
Temperature Manipulating Gloves for the Treatment of Insomnia
NCT02341287
Integrative-omics of the Disordered COPD Small Airway Epithelium
NCT02183818
Reduction of Peanut Reactivity and Immune Modulation With Anti-IgE Therapy
NCT02194530
Study of Clinical Efficacy and Safety of Tosedostat in MDS
NCT02452346
Efficacy of Quetiapine for Pediatric Delirium
NCT02056171
Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR
NCT02497404
Hormonal Predictors of Oncologic Surgery
NCT02471157
Stem Cell Monitoring for CML Patients Undergoing Nilotinib Therapy
NCT02353728
Use of Rotational Thromboelastometry (ROTEM) to Characterize Coagulation Abnormalities in Burn Patients
NCT02388776
Case Studies: Promoting Strategy Use in Functional Activities
NCT04363645
Doxycycline for COPD in HIV-Infected Patients
NCT01744093
Depression, Obesity and Inflammatory Markers
NCT02765100
Identification and Treatment of Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants
NCT02604420
Aggressive Onset Multiple Sclerosis: A Practical Definition and Study of Its Clinical Course
NCT02301572
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 111 |
| Phase 3 | 26 |
| Phase 4 | 63 |
Therapeutic Areas
What is open in the Weill Medical College of Cornell University pipeline
127 recruiting of 701 indexed (18% open); 387 completed (55%).
Phase mix: 89 late (III/IV) vs 197 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Weill Medical College of Cornell University: open-pipeline peers nationwide
Peers matched on 701 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Weill Medical College of Cornell University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 701 trials (± recruiting share)
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Sanofi · 713 trials · 10% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Children's Hospital of Philadelphia · 18% recruiting · 431 trials
- University of California, Berkeley · 18% recruiting · 72 trials
- Burke Medical Research Institute · 18% recruiting · 11 trials
- Grand Valley State University · 18% recruiting · 11 trials
Related
What to do with this Weill Medical College of Cornell University page
701 registered trials is a research-attention snapshot, not an endorsement of Weill Medical College of Cornell University or any single study.
- 127 of Weill Medical College of Cornell University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Weill Medical College of Cornell University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Weill Medical College of Cornell University pipeline card: 701 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.